Corindus Vascular Robotics
Waltham, US · Founded 2011 · Delaware corporation · 2 known investors
Founders & leadership
SJ
Stephen J. LemasterExecutive
MJ
Mark J. TolandExecutive
DW
David W. LongExecutive
JC
Jeffrey C LightcapChairman
DW
David W LongNamed on SEC filing
MM
Michael MashaalNamed on SEC filing
JG
Jeffrey GoldNamed on SEC filing
DM
David M HandlerNamed on SEC filing
DW
David WhiteNamed on SEC filing
Board
JC
Jeffrey C. LightcapBoard director
LA
Louis A. CannonBoard director
GW
Gerard WinkelsBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$117.1M disclosed across 7 rounds · 2014–2019
▶$4.8MraisedMar 2019 · 3 investors · Other Health CareRule 506(b)
▶$4.8MraisedMar 2019 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas TeanyExecutive Officer
- Nathan R. HarringtonDirector
- James R. TobinDirector
- Campbell D. RogersDirector
- David W. LongExecutive Officer
- Mark J. TolandExecutive Officer, Director
- Douglas L. BraunsteinDirector
- Jeffrey G. GoldDirector
- Louis A. CannonDirector
- Jeffrey C. LightcapDirector
- Offering amount
- $4.8M
- Amount sold
- $4.8M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$413.9KraisedMar 2019 · 2 investors · Other Health CareRule 506(b)
▶$413.9KraisedMar 2019 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas TeanyExecutive Officer
- Campbell D. RogersDirector
- Nathan R. HarringtonDirector
- Douglas L. BraunsteinDirector
- Jeffrey C. LightcapDirector
- Jeffrey G. GoldDirector
- Mark J. TolandExecutive Officer, Director
- David W. LongExecutive Officer
- James R. TobinDirector
- Louis A. CannonDirector
- Offering amount
- $413.9K
- Amount sold
- $413.9K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedMar 2019 · 1 investors · Other Health CareRule 506(b)
▶$15MraisedMar 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey C. LightcapDirector
- Douglas TeanyExecutive Officer
- David W. LongExecutive Officer
- Campbell D. RogersDirector
- James R. TobinDirector
- Nathan R. HarringtonDirector
- Douglas L. BraunsteinDirector
- Mark J. TolandExecutive Officer, Director
- Louis A. CannonDirector
- Jeffrey G. GoldDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedMar 2018 · 4 investors · Other Health CareRule 506(b)
▶$25MraisedMar 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey G. GoldDirector
- Douglas L. BraunsteinDirector
- Campbell D. RogersDirector
- Nthan R. HarringtonDirector
- Jeffrey C. LightcapDirector
- Mark J. TolandExecutive Officer, Director
- David W. LongExecutive Officer
- Louis A. CannonDirector
- James R. TobinDirector
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$180KraisedMar 2018 · 2 investors · Other Health CareRule 506(b)
▶$180KraisedMar 2018 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas L. BraunsteinDirector
- James R. TobinDirector
- Jeffrey C. LightcapDirector
- Jeffrey G. GoldDirector
- Nathan R. HarringtonDirector
- Campbell D. RogersDirector
- Louis A. CannonDirector
- David W. LongExecutive Officer
- Mark J. TolandExecutive Officer, Director
- Offering amount
- $180K
- Amount sold
- $180K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$45MraisedMar 2017 · 16 investors · Other Health CareRule 506(b)
▶$45MraisedMar 2017 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey C. LightcapDirector
- Campbell D. RogersDirector
- Stephen J. LemasterExecutive Officer
- Louis A. CannonDirector
- Mark J. TolandExecutive Officer, Director
- Jeffrey G. GoldDirector
- David W. LongExecutive Officer
- Gerard WinkelsDirector
- Offering amount
- $45M
- Amount sold
- $45M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$26.7MraisedSep 2014 · 15 investors · Other Health CareRule 506(c)
▶$26.7MraisedSep 2014 · 15 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Jeffrey C LightcapDirector
- David W LongExecutive Officer
- Michael MashaalDirector
- Jeffrey GoldDirector
- David M HandlerExecutive Officer, Director
- Gerard WinkelsDirector
- Hillel BachrachDirector
- David WhiteDirector
- Offering amount
- $26.7M
- Amount sold
- $26.7M
- Minimum investment
- $100K
- Sales commissions
- $1M
- Placement agents
- Cowen and Company, LLC, Stifel, Nicolaus & Company, Incorporated
- First sale
- Sep 2014
- Incorporated
- Corporation, Nevada, 2011
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Corindus Vascular Robotics's investors?
- Corindus Vascular Robotics's investors include 20/20 HealthCare Partners LLC, BioStar Ventures.
- How much funding has Corindus Vascular Robotics raised?
- Corindus Vascular Robotics has disclosed $117.1M raised across 7 rounds.
- Where is Corindus Vascular Robotics headquartered?
- Corindus Vascular Robotics is headquartered in Waltham, US.